In non-controlled studies, in which lamivudina was suppressed before and during pregnancy, it demonstrated an effective suppression of HBV DNA and normalization of ALT.
In studi non controllati, nei quali lamivudina veniva somministrata prima e durante il trapianto, veniva dimostrata un’efficace soppressione dell’HBV DNA e la normalizzazione di ALT.